Applied Therapeutics, Inc. is a US-based biopharmaceutical company focused on developing novel product candidates to address unmet medical needs. Their lead product, AT-007, has completed phase 3 trials for galactosemia treatment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing